Please assess the completion status of the following clinical trial:

Trial Title: Effects of Celecoxib After Percutaneous Coronary Intervention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Coronary artery disease with at least 1 de novo lesion greater than 50% stenosis on coronary angiography~Exclusion Criteria:~* Acute ST elevation MI~* Left main disease~* Contraindications to aspirin, clopidogrel or celecoxib~* Severe congestive heart failure~* Expected survival \< 2 years~* Hepatic dysfunction~* Currently taking NSAIDs or any COX-2 inhibitor~* Renal dysfunction~* Use of warfarin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): None
- Celecoxib (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).